Lida Tehrani

1.5k total citations
19 papers, 1.0k citations indexed

About

Lida Tehrani is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Lida Tehrani has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 3 papers in Genetics. Recurrent topics in Lida Tehrani's work include Neuroscience and Neuropharmacology Research (12 papers), Chemical Synthesis and Analysis (3 papers) and Molecular Sensors and Ion Detection (3 papers). Lida Tehrani is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Chemical Synthesis and Analysis (3 papers) and Molecular Sensors and Ion Detection (3 papers). Lida Tehrani collaborates with scholars based in United States. Lida Tehrani's co-authors include Nicholas D. P. Cosford, Mark A. Varney, Sara Rao, Jeffrey Roppe, Edwin J. Schweiger, Jesse Brodkin, Linda J. Bristow, Xiaohui Jiang, Jeffrey Anderson and Nicholas D. Smith and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Neuropsychopharmacology.

In The Last Decade

Lida Tehrani

19 papers receiving 975 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lida Tehrani 683 551 192 124 60 19 1.0k
Julie A. O’Brien 971 1.4× 849 1.5× 137 0.7× 144 1.2× 40 0.7× 30 1.3k
Jeffrey Roppe 607 0.9× 569 1.0× 216 1.1× 81 0.7× 104 1.7× 19 1.1k
Matthew J. Valli 598 0.9× 499 0.9× 225 1.2× 117 0.9× 32 0.5× 16 858
Thomas J. Woltering 526 0.8× 603 1.1× 323 1.7× 108 0.9× 49 0.8× 33 1.0k
Eric Vieira 542 0.8× 825 1.5× 430 2.2× 99 0.8× 55 0.9× 25 1.4k
Hilde Lavreysen 1.1k 1.6× 1.0k 1.9× 151 0.8× 115 0.9× 50 0.8× 51 1.5k
Ann Marie L. Ogden 568 0.8× 429 0.8× 121 0.6× 166 1.3× 74 1.2× 17 846
Wei Lemaire 881 1.3× 784 1.4× 122 0.6× 189 1.5× 38 0.6× 25 1.2k
Laétitia Mony 832 1.2× 749 1.4× 96 0.5× 73 0.6× 80 1.3× 23 1.2k
Yelin Chen 731 1.1× 685 1.2× 107 0.6× 156 1.3× 80 1.3× 31 1.3k

Countries citing papers authored by Lida Tehrani

Since Specialization
Citations

This map shows the geographic impact of Lida Tehrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lida Tehrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lida Tehrani more than expected).

Fields of papers citing papers by Lida Tehrani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lida Tehrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lida Tehrani. The network helps show where Lida Tehrani may publish in the future.

Co-authorship network of co-authors of Lida Tehrani

This figure shows the co-authorship network connecting the top 25 collaborators of Lida Tehrani. A scholar is included among the top collaborators of Lida Tehrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lida Tehrani. Lida Tehrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Norris, Stephen H., Dehua Huang, Gody Khambatta, et al.. (2023). Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation. Journal of Medicinal Chemistry. 66(23). 16388–16409. 30 indexed citations
2.
Robinson, Dale, Sogole Bahmanyar, Lida Tehrani, et al.. (2021). Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity. Journal of Medicinal Chemistry. 64(17). 12670–12679. 5 indexed citations
3.
Riggs, Jennifer R., Dale Robinson, Lida Tehrani, et al.. (2019). Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy. Journal of Medicinal Chemistry. 62(9). 4401–4410. 17 indexed citations
4.
Siu, Tony, Yiwei Li, Johnny Nagasawa, et al.. (2008). The design and synthesis of potent and cell-active allosteric dual Akt 1 and 2 inhibitors devoid of hERG activity. Bioorganic & Medicinal Chemistry Letters. 18(14). 4191–4194. 13 indexed citations
5.
Tehrani, Lida, Nicholas D. Smith, Dehua Huang, et al.. (2005). 3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: Identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(22). 5061–5064. 10 indexed citations
6.
Chua, Peter, Johnny Nagasawa, Leo Bleicher, et al.. (2005). Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(20). 4589–4593. 11 indexed citations
7.
Bradbury, Margaret, Una C. Campbell, Deborah F. Chapman, et al.. (2005). Metabotropic Glutamate Receptor mGlu5 Is a Mediator of Appetite and Energy Balance in Rats and Mice. Journal of Pharmacology and Experimental Therapeutics. 313(1). 395–402. 75 indexed citations
8.
9.
Brodkin, Jesse, Jeffery J. Anderson, Lida Tehrani, et al.. (2004). The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety. Neuropsychopharmacology. 29(11). 1971–1979. 137 indexed citations
10.
Huang, Dehua, Steve F. Poon, Deborah F. Chapman, et al.. (2004). 2-{2-[3-(Pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl}pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 14(22). 5473–5476. 25 indexed citations
11.
Roppe, Jeffrey, Bowei Wang, Dehua Huang, et al.. (2004). 5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3′-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity. Bioorganic & Medicinal Chemistry Letters. 14(15). 3993–3996. 41 indexed citations
12.
Hu, Essa, Peter Chua, Lida Tehrani, et al.. (2004). Pyrimidine methyl anilines: selective potentiators for the metabotropic glutamate 2 receptor. Bioorganic & Medicinal Chemistry Letters. 14(20). 5071–5074. 12 indexed citations
13.
Smith, Nicholas D., Steve F. Poon, Dehua Huang, et al.. (2004). Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 14(22). 5481–5484. 12 indexed citations
14.
Cosford, Nicholas D. P., Jeffrey Roppe, Lida Tehrani, et al.. (2003). [3H]-Methoxymethyl-MTEP and [3H]-Methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor. Bioorganic & Medicinal Chemistry Letters. 13(3). 351–354. 123 indexed citations
15.
Anderson, Jeffery J., Sara Rao, Blake A. Rowe, et al.. (2002). [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization. Journal of Pharmacology and Experimental Therapeutics. 303(3). 1044–1051. 93 indexed citations
16.
Cosford, Nicholas D. P., Lida Tehrani, Jeffrey Roppe, et al.. (2002). 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]- pyridine:  A Potent and Highly Selective Metabotropic Glutamate Subtype 5 Receptor Antagonist with Anxiolytic Activity. Journal of Medicinal Chemistry. 46(2). 204–206. 348 indexed citations
17.
Cottam, Howard B., Hsiencheng Shih, Lida Tehrani, D B Wasson, & Dennis A. Carson. (1996). Substituted Xanthines, Pteridinediones, and Related Compounds as Potential Antiinflammatory Agents. Synthesis and Biological Evaluation of Inhibitors of Tumor Necrosis Factor α. Journal of Medicinal Chemistry. 39(1). 2–9. 41 indexed citations
18.
19.
Melacini, Giuseppe, et al.. (1994). Synthesis and physicochemical characterization of the lanthionine analog of somatostatin[1?14]. Letters in Peptide Science. 1(2). 81–87. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie A. O’Brien Breakdown of academic impact, for papers by Jeffrey Roppe Breakdown of academic impact, for papers by Matthew J. Valli Breakdown of academic impact, for papers by Thomas J. Woltering Breakdown of academic impact, for papers by Eric Vieira Breakdown of academic impact, for papers by Hilde Lavreysen Breakdown of academic impact, for papers by Ann Marie L. Ogden Breakdown of academic impact, for papers by Wei Lemaire Breakdown of academic impact, for papers by Laétitia Mony Breakdown of academic impact, for papers by Yelin Chen
Rankless by CCL
2026